2m 2m 2m 2m 2m 2m 2m
Supernus Pharm (SUPN)
NASDAQ
$51.16+$6.52 (+14.62%)
Price as of Aug 03, 2026 9:04 AM EDT- $2.6BMarket Cap
- 25.70%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Supernus Pharm (SUPN)
$51.16+$6.52 (+14.62%)
Earnings Score
Valuation | SUPN | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 0 | ||
Growth | -0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | SUPN | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -2.63% | ||
12-Month Momentum | 35.07% | ||
3-Month Risk Adjusted Momentum | -20.41% | ||
12-Month Risk Adjusted Momentum | 98.86% |
True Yield
Valuation | SUPN | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | SUPN | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 7 |